Live feed08:00:00·505dPRReleasevia QuantisnowErasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic CancerByQuantisnow·Wall Street's wire, on your screen.AIM· AIM ImmunoTech Inc.Health Care
